Biosynth strengthens peptide business with acquisition of Cambridge Research Biochemicals
Biosynth, a supplier of critical raw materials to the life science industry, has acquired Cambridge Research Biochemicals (CRB), a leading independent producer of custom-made peptide and antibody tools, based in the UK and supplying researchers in the pharmaceutical, life science and academic sectors.